VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32 | +28.0% | 258,749 | +6.6% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 242,689 | +1.7% | 0.00% | – |
| Q3 2022 | $36,000 | -81.5% | 238,524 | +7.5% | 0.00% | – |
| Q2 2022 | $195,000 | -18.4% | 221,784 | +15.0% | 0.00% | – |
| Q1 2022 | $239,000 | -21.9% | 192,881 | +22.8% | 0.00% | – |
| Q4 2021 | $306,000 | -30.3% | 157,025 | -2.0% | 0.00% | -100.0% |
| Q3 2021 | $439,000 | -2.2% | 160,245 | +12.3% | 0.00% | 0.0% |
| Q2 2021 | $449,000 | – | 142,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |